The global autoimmune disease diagnostics market is likely to experience an upsurge owing to the increased prevalence of autoimmune disease , emerging awareness regarding autoimmune diseases, and rising expenditure on healthcare. The increasing spending on RD activities coupled with the aggressive strategies adopted by the top market players like new product launches along with mergers and acquisitions are anticipated to contribute to the market growth across the globe. For instance, Abbott acquired Alere Inc. in October 2017 for USD 5.3 billion. The deal will enable Abbott to gain control over USD 7 billion diagnostics sales of Alere Inc. and also strengthen their position in the global market.